MENU
+Compare
AXON
Stock ticker: NASDAQ
AS OF
Jan 22, 03:27 PM (EDT)
Price
$604.67
Change
-$0.91 (-0.15%)
Capitalization
46.18B

AXON Axon Enterprise Forecast, Technical & Fundamental Analysis

a clinical-stage biopharmaceutical company

AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for AXON with price predictions
Jan 08, 2025

AXON's RSI Indicator ascends from oversold territory

The RSI Indicator for AXON moved out of oversold territory on January 08, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 24 similar instances when the indicator left oversold territory. In of the 24 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AXON advanced for three days, in of 379 cases, the price rose further within the following month. The odds of a continued upward trend are .

AXON may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

AXON moved below its 50-day moving average on January 06, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXON declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AXON entered a downward trend on January 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 69, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AXON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (21.552) is normal, around the industry mean (9.198). AXON has a moderately high P/E Ratio (154.257) as compared to the industry average of (61.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.354). AXON has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (23.641) is also within normal values, averaging (7.994).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

View a ticker or compare two or three
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

AXON is expected to report earnings to fall 3.45% to $1.40 per share on March 04

Axon Enterprise AXON Stock Earnings Reports
Q4'24
Est.
$1.40
Q3'24
Beat
by $0.26
Q2'24
Beat
by $0.18
Q1'24
Beat
by $0.20
Q4'23
Missed
by $0.10
The last earnings report on November 07 showed earnings per share of $1.45, beating the estimate of $1.19. With 62.16K shares outstanding, the current market capitalization sits at 46.18B.
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company

Industry AerospaceDefense

Profile
Fundamentals
Details
Industry
Biotechnology
Address
17800 North 85th Street
Phone
+1 480 991-0797
Employees
4260
Web
https://investor.axon.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMPG2.170.14
+6.90%
Amplitech Group
AMTD1.050.02
+2.42%
AMTD IDEA Group
COGT8.200.17
+2.12%
Cogent Biosciences
FTS42.540.59
+1.41%
Fortis
CGEN2.270.02
+0.89%
Compugen Ltd

AXON and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AXON has been loosely correlated with TECH. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if AXON jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXON
1D Price
Change %
AXON100%
+1.97%
TECH - AXON
61%
Loosely correlated
+3.85%
VCYT - AXON
58%
Loosely correlated
+7.44%
BEAM - AXON
57%
Loosely correlated
+4.65%
SEER - AXON
56%
Loosely correlated
+3.06%
ADPT - AXON
56%
Loosely correlated
+9.40%
More